Peter J. Norsworthy

1.2k total citations
21 papers, 794 citations indexed

About

Peter J. Norsworthy is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Peter J. Norsworthy has authored 21 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Rheumatology. Recurrent topics in Peter J. Norsworthy's work include Complement system in diseases (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Systemic Lupus Erythematosus Research (6 papers). Peter J. Norsworthy is often cited by papers focused on Complement system in diseases (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Systemic Lupus Erythematosus Research (6 papers). Peter J. Norsworthy collaborates with scholars based in United Kingdom and Egypt. Peter J. Norsworthy's co-authors include Mark Walport, Kevin Davies, Marina Botto, Panagiotis Athanassiou, Philip R. Taylor, Jean Taylor‐Wiedeman, Paul Bowness, Leszek K. Borysiewicz, Simon D. Taylor‐Robinson and P Meyer and has published in prestigious journals such as The Journal of Immunology, Statistics in Medicine and Lara D. Veeken.

In The Last Decade

Peter J. Norsworthy

21 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Norsworthy United Kingdom 12 510 264 162 123 110 21 794
Uri Arad Israel 14 213 0.4× 231 0.9× 61 0.4× 170 1.4× 116 1.1× 31 692
Matthew D. Cascino United States 10 233 0.5× 311 1.2× 124 0.8× 82 0.7× 71 0.6× 20 604
Ferdinand C. Breedveld Netherlands 11 392 0.8× 507 1.9× 235 1.5× 101 0.8× 51 0.5× 12 879
Thi Migone United States 7 594 1.2× 129 0.5× 88 0.5× 141 1.1× 84 0.8× 13 896
Otto Prümmer Germany 16 239 0.5× 149 0.6× 97 0.6× 89 0.7× 215 2.0× 42 798
Svetlana Sosnovtseva United States 5 609 1.2× 194 0.7× 170 1.0× 83 0.7× 52 0.5× 6 771
Daha Mr Netherlands 18 513 1.0× 180 0.7× 116 0.7× 131 1.1× 38 0.3× 59 995
Daniela Novick Israel 11 655 1.3× 103 0.4× 84 0.5× 364 3.0× 126 1.1× 13 1.1k
D S Pisetsky United States 19 692 1.4× 378 1.4× 450 2.8× 224 1.8× 34 0.3× 30 996

Countries citing papers authored by Peter J. Norsworthy

Since Specialization
Citations

This map shows the geographic impact of Peter J. Norsworthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Norsworthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Norsworthy more than expected).

Fields of papers citing papers by Peter J. Norsworthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Norsworthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Norsworthy. The network helps show where Peter J. Norsworthy may publish in the future.

Co-authorship network of co-authors of Peter J. Norsworthy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Norsworthy. A scholar is included among the top collaborators of Peter J. Norsworthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Norsworthy. Peter J. Norsworthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elgharably, Ahmed, et al.. (2016). Hepatitis C in Egypt – past, present, and future. International Journal of General Medicine. Volume 10. 1–6. 119 indexed citations
2.
Mason, Alexina J., Killian Quinn, Peter J. Norsworthy, et al.. (2016). Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment. Statistics in Medicine. 36(5). 754–771. 7 indexed citations
3.
Hunnangkul, Saowalak, Dorothea Nitsch, Benjamin Rhodes, et al.. (2008). Familial clustering of non‐nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis & Rheumatism. 58(4). 1116–1124. 11 indexed citations
4.
Fossati‐Jimack, Liliane, Josefina Cortés-Hernández, Peter J. Norsworthy, et al.. (2008). Regulation of B cell tolerance by 129‐derived chromosome 1 loci in C57BL/6 mice. Arthritis & Rheumatism. 58(7). 2131–2141. 10 indexed citations
5.
Fossati‐Jimack, Liliane, Josefina Cortés-Hernández, Peter J. Norsworthy, et al.. (2007). C1q deficiency promotes the production of transgenic-derived IgM and IgG3 autoantibodies in anti-DNA knock-in transgenic mice. Molecular Immunology. 45(3). 787–795. 13 indexed citations
6.
Larkin, James, et al.. (2006). Anti-αGal-dependent complement-mediated cytotoxicity in metastatic melanoma. Melanoma Research. 16(2). 157–163. 7 indexed citations
7.
Norsworthy, Peter J., Liliane Fossati‐Jimack, Josefina Cortés-Hernández, et al.. (2004). Murine CD93 (C1qRp) Contributes to the Removal of Apoptotic Cells In Vivo but Is Not Required for C1q-Mediated Enhancement of Phagocytosis. The Journal of Immunology. 172(6). 3406–3414. 116 indexed citations
8.
Norsworthy, Peter J. & Kelvin J.A. Davies. (2003). Complement Components and Their Autoantibodies. Molecular Biotechnology. 23(3). 259–270. 9 indexed citations
9.
Davies, Kevin & Peter J. Norsworthy. (2003). Autoantibodies to Complement Components. Humana Press eBooks. 150. 173–192. 3 indexed citations
10.
Davies, Kevin A., et al.. (2002). Defective Fc‐dependent processing of immune complexes in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 46(4). 1028–1038. 41 indexed citations
11.
Taylor, Philip R., et al.. (2001). Immune complex processing in C1q-deficient mice. Clinical & Experimental Immunology. 123(2). 196–202. 35 indexed citations
12.
Loizou, S., et al.. (2000). Significance of anticardiolipin and anti‐β2‐glycoprotein I antibodies in lupus nephritis. Lara D. Veeken. 39(9). 962–968. 27 indexed citations
13.
Norsworthy, Peter J., et al.. (2000). Targeted disruption of the murine phagocytic receptor ClqRp and phenotypic analysis. Immunopharmacology. 49(1-2). 36–36. 1 indexed citations
14.
Norsworthy, Peter J., Philip R. Taylor, Mark Walport, & Marina Botto. (1999). Cloning of the mouse homolog of the 126-kDa human C1q/MBL/SP-A receptor, C1qR p. Mammalian Genome. 10(8). 789–793. 18 indexed citations
15.
Norsworthy, Peter J., Efstathios Theodoridis, Marina Botto, et al.. (1999). Overrepresentation of the Fc? receptor type IIA R131/R131 genotype in Caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis & Rheumatism. 42(9). 1828–1832. 75 indexed citations
16.
Norsworthy, Peter J., et al.. (1996). Homozygous hereditary C1q deficiency and systemic lupus erythematosus: A new family and the molecular basis of C1q deficiency in three families. Arthritis & Rheumatism. 39(4). 663–670. 70 indexed citations
17.
Mitchell, Tracey J., et al.. (1996). IFN-γ up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. The Journal of Immunology. 156(11). 4429–4434. 40 indexed citations
18.
Seelen, Marc A., Panagiotis Athanassiou, William Lynn, et al.. (1995). The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.. PubMed. 84(4). 653–61. 10 indexed citations
19.
Bowness, Paul, Kevin Davies, Peter J. Norsworthy, et al.. (1994). Hereditary C1q deficiency and systemic lupus erythematosus. QJM. 87(8). 455–64. 157 indexed citations
20.
Tonoli, M., Kevin Davies, Peter J. Norsworthy, José L. Cohen, & Mark Walport. (1993). The anti-lipid A antibody HA-IA binds to rough Gram-negative bacteria, fixes complement and facilitates binding to erythrocyte CRl (CD35). Clinical & Experimental Immunology. 92(2). 232–238. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uri Arad Breakdown of academic impact, for papers by Matthew D. Cascino Breakdown of academic impact, for papers by Ferdinand C. Breedveld Breakdown of academic impact, for papers by Thi Migone Breakdown of academic impact, for papers by Otto Prümmer Breakdown of academic impact, for papers by Svetlana Sosnovtseva Breakdown of academic impact, for papers by Daha Mr Breakdown of academic impact, for papers by Daniela Novick Breakdown of academic impact, for papers by D S Pisetsky
Rankless by CCL
2026